Ivantis

Irvine, United States Founded: 2007 • Age: 19 yrs Acquired By Alcon
Implantable device to relieve intraocular pressure in open angle glaucoma
Request Access

About Ivantis

Ivantis is a company based in Irvine (United States) founded in 2007 was acquired by Alcon in November 2021.. Ivantis has raised $166.23 million across 7 funding rounds from investors including Alcon, RA Capital and Merieux Equity Partners. The company has 132 employees as of December 31, 2022. Ivantis operates in a competitive market with competitors including Glaukos, Myra Vision, Sensimed, Transcend Medical and Avisi Technologies, among others.

  • Headquarter Irvine, United States
  • Employees 132 as on 31 Dec, 2022
  • Sectors
    Technology
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ivantis, Inc.
Operational Areas
Technology → Extended, Virtual & Augmented Reality
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $166.23 M (USD)

    in 7 rounds

  • Latest Funding Round
    $25 M (USD), Series C

    Jan 20, 2017

  • Investors
    Alcon

    & 10 more

  • Employee Count
    132

    as on Dec 31, 2022

  • Acquired by
    Alcon

    (Nov 08, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Ivantis

Ivantis has successfully raised a total of $166.23M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series C — $25.0M
  • First Round

    (01 Jun 2008)

  • Investors Count 10
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2017 Amount Series C - Ivantis Valuation RA Capital Management
Oct, 2014 Amount Series C - Ivantis Valuation GBS , Vertex Ventures HC
Jan, 2014 Amount Series B - Ivantis Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ivantis

Ivantis has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Alcon, RA Capital and Merieux Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Pivate equity firm that focuses on investing in healthcare and nutrition companies
Founded Year Domain Location
Venture capital investments are offered to startups by NEA.
Founded Year Domain Location
Investments are made in life sciences firms across all stages.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ivantis

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ivantis

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ivantis Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ivantis

Ivantis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Myra Vision, Sensimed, Transcend Medical and Avisi Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of implants to treat glaucoma
domain founded_year HQ Location
Nanotechnology-based devices for glaucoma treatment are developed.
domain founded_year HQ Location
A contact lens-based platform for glaucoma monitoring is offered.
domain founded_year HQ Location
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
domain founded_year HQ Location
Nano-materials for glaucoma treatment implants are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ivantis

Frequently Asked Questions about Ivantis

When was Ivantis founded?

Ivantis was founded in 2007 and raised its 1st funding round 1 year after it was founded.

Where is Ivantis located?

Ivantis is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

Is Ivantis a funded company?

Ivantis is a funded company, having raised a total of $166.23M across 7 funding rounds to date. The company's 1st funding round was a Series B of $14M, raised on Jun 01, 2008.

How many employees does Ivantis have?

As of Dec 31, 2022, the latest employee count at Ivantis is 132.

What does Ivantis do?

Ivantis Inc. was founded in 2007 in Irvine, United States, focusing on medical devices for ophthalmology. Solutions for primary open-angle glaucoma are developed by the company, including an intracanalicular scaffold designed as an implantable device. High intraocular pressures in patients are addressed through this technology. Operations center on innovation in glaucoma treatment, with the domain ivantisinc.com serving as the primary online presence.

Who are the top competitors of Ivantis?

Ivantis's top competitors include Glaukos, Myra Vision and Avisi Technologies.

Who are Ivantis's investors?

Ivantis has 11 investors. Key investors include Alcon, RA Capital, Merieux Equity Partners, NEA, and Delphi Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available